39208367|t|CSF alpha-Synuclein Seed Amplification Assay in Patients With Atypical Parkinsonian Disorders.
39208367|a|BACKGROUND AND OBJECTIVES: There is no disease-modifying treatment of corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP), 2 disorders characterized by their striking phenotypic, and, in CBS, pathologic heterogeneity. Seed amplification assays (SAAs) could enable the detection of neuropathologic processes, such as alpha-synuclein (alphaSyn) copathology, that affect the success of future disease-modifying treatment strategies. The primary objective was to assess possible alphaSyn copathology in CBS and PSP, as detected in CSF using an alphaSyn SAA (alphaSyn-SAA). Secondary objectives were to evaluate the association of alphaSyn-SAA positivity with other biomarkers including of Alzheimer disease (AD), and with clinical presentation. We hypothesized that alphaSyn-SAA positivity would be detectable in CBS and PSP and that it would be associated with AD biomarker positivity and beta-amyloid (Abeta) 42 levels, neurodegeneration as assessed by neurofilament light chain (NfL) levels, and symptoms associated with synucleinopathies. METHODS: This cross-sectional observational study included patients clinically diagnosed with CBS and PSP who underwent a lumbar puncture between 2012 and 2021 (Toronto Western Hospital, Canada). CSF was tested for alphaSyn-SAA positivity, AD biomarkers, and NfL levels. Clinical data were derived from medical records. RESULTS: We tested the CSF of 40 patients with CBS (19 female patients, 65.9 +- 8.6 years) and 28 with PSP (13 female patients, 72.5 +- 8.7 years old), mostly White (n = 50) or Asian (n = 14). alphaSyn-SAA positivity was observed in 35.9% patients with CBS and 28.6% with PSP. In young-onset, but not late-onset patients, alphaSyn-SAA positivity and AD positivity were associated (odds ratio [OR] 8.8, 95% CI 1.2-82.6, p < 0.05). A multivariable linear regression analysis showed a significant interaction of alphaSyn-SAA status by age at onset on CSF Abeta42 levels (beta = 0.3 +- 0.1, p < 0.05). Indeed, age at onset was positively related to Abeta42 levels only in alphaSyn-SAA-positive patients, as shown by slope comparison. A logistic regression analysis also suggested that REM sleep behavior disorder was associated with alphaSyn-SAA positivity (OR 60.2, 95% CI 5.2-1,965.8; p < 0.01). DISCUSSION: We detected a frequency of alphaSyn-SAA positivity in CBS and PSP in line with pathologic studies, highlighting the usefulness of SAAs for in vivo detection of otherwise undetectable neuropathologic processes. Our results also suggest that AD status (specifically low Abeta42) and older age at onset may contribute to alphaSyn-SAA positivity. This opens new perspectives for the stratification of patients in clinical trials.
39208367	4	19	alpha-Synuclein	Gene	6622
39208367	48	56	Patients	Species	9606
39208367	71	93	Parkinsonian Disorders	Disease	MESH:D010300
39208367	165	186	corticobasal syndrome	Disease	MESH:D000088282
39208367	188	191	CBS	Disease	MESH:D000088282
39208367	197	227	progressive supranuclear palsy	Disease	MESH:D013494
39208367	229	232	PSP	Disease	MESH:D013494
39208367	299	302	CBS	Disease	MESH:D000088282
39208367	428	443	alpha-synuclein	Gene	6622
39208367	445	453	alphaSyn	Gene	6622
39208367	587	595	alphaSyn	Gene	6622
39208367	611	614	CBS	Disease	MESH:D000088282
39208367	619	622	PSP	Disease	MESH:D013494
39208367	652	660	alphaSyn	Gene	6622
39208367	661	664	SAA	Gene	6287
39208367	666	674	alphaSyn	Gene	6622
39208367	675	678	SAA	Gene	6287
39208367	738	746	alphaSyn	Gene	6622
39208367	747	750	SAA	Gene	6287
39208367	797	814	Alzheimer disease	Disease	MESH:D000544
39208367	816	818	AD	Disease	MESH:D000544
39208367	874	882	alphaSyn	Gene	6622
39208367	883	886	SAA	Gene	6287
39208367	921	924	CBS	Disease	MESH:D000088282
39208367	929	932	PSP	Disease	MESH:D013494
39208367	970	972	AD	Disease	MESH:D000544
39208367	1030	1047	neurodegeneration	Disease	MESH:D019636
39208367	1063	1088	neurofilament light chain	Gene	4747
39208367	1090	1093	NfL	Gene	4747
39208367	1132	1149	synucleinopathies	Disease	MESH:D000080874
39208367	1210	1218	patients	Species	9606
39208367	1245	1248	CBS	Disease	MESH:D000088282
39208367	1253	1256	PSP	Disease	MESH:D013494
39208367	1366	1374	alphaSyn	Gene	6622
39208367	1375	1378	SAA	Gene	6287
39208367	1391	1393	AD	Disease	MESH:D000544
39208367	1410	1413	NfL	Gene	4747
39208367	1504	1512	patients	Species	9606
39208367	1518	1521	CBS	Disease	MESH:D000088282
39208367	1533	1541	patients	Species	9606
39208367	1574	1577	PSP	Disease	MESH:D013494
39208367	1589	1597	patients	Species	9606
39208367	1664	1672	alphaSyn	Gene	6622
39208367	1673	1676	SAA	Gene	6287
39208367	1710	1718	patients	Species	9606
39208367	1724	1727	CBS	Disease	MESH:D000088282
39208367	1743	1746	PSP	Disease	MESH:D013494
39208367	1783	1791	patients	Species	9606
39208367	1793	1801	alphaSyn	Gene	6622
39208367	1802	1805	SAA	Gene	6287
39208367	1821	1823	AD	Disease	MESH:D000544
39208367	1980	1988	alphaSyn	Gene	6622
39208367	1989	1992	SAA	Gene	6287
39208367	2023	2030	Abeta42	Gene	351
39208367	2116	2123	Abeta42	Gene	351
39208367	2139	2147	alphaSyn	Gene	6622
39208367	2148	2151	SAA	Gene	6287
39208367	2161	2169	patients	Species	9606
39208367	2252	2279	REM sleep behavior disorder	Disease	MESH:D020187
39208367	2300	2308	alphaSyn	Gene	6622
39208367	2309	2312	SAA	Gene	6287
39208367	2404	2412	alphaSyn	Gene	6622
39208367	2413	2416	SAA	Gene	6287
39208367	2431	2434	CBS	Disease	MESH:D000088282
39208367	2439	2442	PSP	Disease	MESH:D013494
39208367	2617	2619	AD	Disease	MESH:D000544
39208367	2645	2652	Abeta42	Gene	351
39208367	2695	2703	alphaSyn	Gene	6622
39208367	2704	2707	SAA	Gene	6287
39208367	2774	2782	patients	Species	9606
39208367	Association	MESH:D020187	6622
39208367	Association	MESH:D000080874	6622
39208367	Association	MESH:D000544	6287
39208367	Association	MESH:D019636	4747
39208367	Association	MESH:D000088282	6287
39208367	Association	MESH:D000544	6622
39208367	Association	MESH:D000088282	6622
39208367	Association	MESH:D010300	6622
39208367	Association	MESH:D019636	6622
39208367	Association	MESH:D013494	6287
39208367	Association	6287	6622
39208367	Association	MESH:D013494	6622

